Прокоагулянтный статус у больных неходжкинскими лимфомами

Introduction. The close interrelation between cancer and thromboses is well proven on today. However usual screening tests are not sensitive to hypercoagulation that limits their use to predict tromboembolic complications.Aim: to study coagulative hemostasis in patients with non-Hodgkin’s lymphomas (NHL) using screening and integral tests in order for their comparison.Materials and methods. We examined 75 patients with first-identified B-cell NHL (40 with aggressive and 35 with indolent lymphomas). Blood coagulation was examined before specific antitumor therapy and after 4 – 6 courses of polyсhemotherapy using coagulogram and « Тhrombodynamics » test.Results. In the diagnosis of disease the significant increasing of initial clot growth rate (Vi), stationary clot growth rate (Vs) and clot size (Cs) were determined. At early stages of disease 26 patients had increased Vs and Cs. 49 patients with generalized stages of NHL had increased Vi, Vs, Cs, prothrombin time by Quick (PT), thrombin time, level of soluble fibrin-monomer com-plexes, shortening of activated partial thrombin time (APTT); in 27 of them (55 %) growth of spontaneous clot away from the ac-tivator was observed. Analysis of procoagulant activity in patients with generalized stages of disease revealed a significant in-creasing of Cs, PT and shortening of APTT. In 34 (45 %) NHL-patients with remission the tendency to hypercoagulation remained.Conclusion. The results obtained indicate a high sensitivity of « Тhrombodynamics » test to procoagulant conditions in pa-tie...